Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.71 |
| ▸ | FAAH | O00519 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.52 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7770695 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL193476 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL15650882 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL25192010 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL17203900 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL25192009 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL17203784 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL5333001 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL19475767 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL19744696 | 1.00 | NOD1 (0.71) | NOD1FAAHMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1094943-C | Urethanes and ureas that induce cytokine production | AMERICAN CYANAMID CO (US) | 2002-11-27 | — | — | CN | disclosed |
| US-5658945-A | ANTICANCER AGENT; AIDS THERAPY; CONTROLLING INFECTIONS | AMERICAN CYANAMID COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| US-5633280-A | ACCELERATED RECOVERY FROM CHEMOTHERAPY, RADIATION TREATMENT, BONE MARROW TRANSPLANTATION, INFECTIONS | AMERICAN CYANAMID COMPANY (US) | 1997-05-27 | — | — | US | disclosed |
| US-5616612-A | THERAPY FOR CANCER, AIDS, ANEMIA, INFECTIONS | AMERICAN CYANAMID COMPANY (US) | 1997-04-01 | — | — | US | disclosed |
| US-5602275-A | MAY BE USED TO ACCELERATE RECOVERY FROM NEUTROPENIA ACCOMPANYING RADIO- OR CHEMOTHERAPY, BONE MARROW TRANSPLANTATION OR INFECTIONS | AMERICAN CYANAMID COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0652228-B1 | Urethanes and ureas that induce cytokine production | AMERICAN CYANAMID CO (US) | 1996-10-23 | — | — | EP | disclosed |
| US-5545662-A | USED TO ACCELERATE RECOVERY FROM NEUTROPENIA ACCOMPANYING RADIO OR CHEMOTHERAPY, BONE MARROW TRANSPLANTATION, OR INFECTIONS | AMERICAN CYANAMID COMPANY (US) | 1996-08-13 | — | — | US | disclosed |
| EP-0652228-A1 | Urethanes and ureas that induce cytokine production | AMERICAN CYANAMID COMPANY (US) | 1995-05-10 | — | — | EP | disclosed |
| CN-1100413-A | Urethanes and ureas that induce cytokine production | AMERICAN CYANAMID CO (US) | 1995-03-22 | — | — | CN | disclosed |
| US-5312831-A | Immunology, anticarcinogenic agents and AIDS treatment | AMERICAN CYANAMID COMPANY (US) | 1994-05-17 | — | — | US | disclosed |
| US-3950277-A | LIPASE ENZYME AND ACTIVATORS, ALKYLNAPHTHALENE SULFONATE | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-13 | — | — | US | disclosed |